Stock Analysts’ Updated EPS Estimates for June 30th (ABVX, ANIX, B, CCL, CFR, CRC, GANX, MSTR, NE, NTR)

Stock Analysts’ updated eps estimates for Tuesday, June 30th:

Abivax (NASDAQ:ABVX) was upgraded by analysts at Jefferies Financial Group Inc. from a hold rating to a buy rating. They currently have $158.00 price target on the stock, up from their previous price target of $108.00.

Anixa Biosciences (NASDAQ:ANIX) had its buy rating reissued by analysts at D. Boral Capital. They currently have a $10.00 price target on the stock.

Barrick Mining (NYSE:B) (TSE:ABX) had its price target cut by UBS Group AG from $54.00 to $50.00. UBS Group AG currently has a buy rating on the stock.

Carnival (NYSE:CCL) had its target price raised by Tigress Financial from $40.00 to $42.00. They currently have a buy rating on the stock.

Cullen/Frost Bankers (NYSE:CFR) had its price target boosted by Citigroup Inc. from $131.00 to $145.00. They currently have a sell rating on the stock.

California Resources (NYSE:CRC) had its target price lowered by Citigroup Inc. from $78.00 to $70.00. They currently have a buy rating on the stock.

Gain Therapeutics (NASDAQ:GANX) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $5.00 target price on the stock.

Strategy (NASDAQ:MSTR) had its target price lowered by BTIG Research from $350.00 to $250.00. The firm currently has a buy rating on the stock.

Noble (NYSE:NE) had its price target reduced by Citigroup Inc. from $52.00 to $45.00. They currently have a neutral rating on the stock.

Nutrien (NYSE:NTR) was upgraded by analysts at Scotia from a sector perform rating to a sector outperform rating. They currently have $80.00 price target on the stock.

Palo Alto Networks (NASDAQ:PANW) had its target price boosted by BTIG Research from $333.00 to $380.00. They currently have a buy rating on the stock.

The PNC Financial Services Group (NYSE:PNC) had its target price increased by Citigroup Inc. from $255.00 to $280.00. They currently have a buy rating on the stock.

Silver Standard Resources (NASDAQ:SSRM) (TSE:SSO) had its target price reduced by UBS Group AG from $43.00 to $40.00. UBS Group AG currently has a buy rating on the stock.

Taysha Gene Therapies (NASDAQ:TSHA) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $12.00 target price on the stock.